Innovating Cancer Drug Discovery with AI and Data

This chapter explores the significant challenges in cancer drug development, emphasizing the high failure rates in clinical trials and the necessity for innovative trial designs. It highlights a startup employing AI to enhance drug discovery by focusing on individual patient characteristics, particularly in colorectal and pancreatic cancers, and discusses their recent funding efforts to advance precision medicine.